is bpc 157 on fda 503a bulks list I just testified at an meeting whether seven popular peptides should be allowed in compounding. Just last month, FDA medical officers determined that none of the peptides met the agency's… A step towards expanded patient

A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this Big decisions could be coming for peptide compounding. Over the next few days, the FDA's Pharmacy Compounding Advisory Committee will discuss several peptides, including BPC 157, and whether they should be considered for Big week for peptides. On July 2324, the FDA's Pharmacy Compounding Advisory Committee will review seven peptide related groups for potential inclusion on the 503A Bulks List. The committee will hear evidence, discuss

SKU: 12516378176 · From iglepidom.org